Acrivon Therapeutics, Inc. Common Stock (ACRV)

Acrivon Therapeutics, Inc. Common Stock (ACRV) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $81.8M; returns 1 day -1.7%, 1 week +5.5%, 1 year -13.5%.

Acrivon Therapeutics, Inc. (ACRV) is a clinical-stage biopharmaceutical company focused on discovering and developing precision oncology medicines using its proprietary Generative Phosphoproteomics AP3 platform.

Groups ACRV belongs to

• Biotechnology
• Clinical Stage Biotech
• Oncology
• Precision Medicine
• Healthcare
• Clinical Stage Biopharma
• Biopharmaceutical
• Cancer Therapeutics
• Fast Track Designation

ACRV financial model: income statement, cash flow and balance sheet